Power Law company profile

Mineralys Therapeutics

Biotech & Life Sciences · Radnor Township, United States · Founded 2020 · IPO 2023 Unicorn

Developing best-in-class, novel therapy for the treatment of hypertension

Valuation

$1.54B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

17 investors on Mineralys Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Adams Street Partners

HBM Partners

Samsara BioCapital

HBM Healthcare Investments

Catalys Pacific

Series B+ 12 investors entered at this stage

Ysios Capital

Boulder Ventures

Andera Partners

RA Capital Management

Sectoral Asset Management

SR One

HealthCor Management

OrbiMed

Venrock

TCGX

Rock Springs Capital

RTW Investments

Global footprint

Where Mineralys Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · Radnor Township HQ

Book a demo for the full country breakdown

Web traffic by country

9.8K monthly visits
across markets

🇺🇸 United States77.6%

🇫🇷 France9.2%

🇬🇧 United Kingdom7.1%

🇮🇳 India5.1%

🇯🇵 Japan1%

Top 5 markets shown

Market sentiment

What the market is saying about Mineralys Therapeutics

An AI-synthesized read of the highest-engagement posts about Mineralys Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mineralys Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles